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Abstract
Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by extended-spectrum b-
lactamase (ESBL)-producing Enterobacteriaceae, but the clinical epidemiology of these infections in low prevalence
countries is largely unknown. A population based case-control study was conducted to assess risk factors for CA-UTI caused
by ESBL-producing E. coli or K. pneumoniae. The study was carried out in a source population in Eastern Norway, a country
with a low prevalence of infections caused by ESBL-producing Enterobacteriaceae. The study population comprised 100
cases and 190 controls with CA-UTI caused by ESBL-producing and non-ESBL-producing E. coli or K. pneumoniae,
respectively. The following independent risk factors of ESBL-positive UTIs were identified: Travel to Asia, The Middle East or
Africa either during the past six weeks (Odds ratio (OR) = 21; 95% confidence interval (CI): 4.5–97) or during the past 6 weeks
to 24 months (OR= 2.3; 95% CI: 1.1–4.4), recent use of fluoroquinolones (OR= 16; 95% CI: 3.2–80) and b-lactams (except
mecillinam) (OR= 5.0; 95% CI: 2.1–12), diabetes mellitus (OR= 3.2; 95% CI: 1.0–11) and recreational freshwater swimming the
past year (OR= 2.1; 95% CI: 1.0–4.0). Factors associated with decreased risk were increasing number of fish meals per week
(OR= 0.68 per fish meal; 95% CI: 0.51–0.90) and age (OR= 0.89 per 5 year increase; 95% CI: 0.82–0.97). In conclusion, we have
identified risk factors that elucidate mechanisms and routes for dissemination of ESBL-producing Enterobacteriaceae in a low
prevalence country, which can be used to guide appropriate treatment of CA-UTI and targeted infection control measures.
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Introduction
During the past 15 years, we have observed a worldwide
dissemination of infections caused by CTX-M extended-spectrum
b-lactamase (ESBL)-producing Enterobacteriaceae [1]. These infec-
tions are associated with increased mortality, morbidity, health
care costs, and the need for broad-spectrum antibiotics [2].
Community-acquired urinary tract infection (CA-UTI) is the most
common infection caused by ESBL-producing bacteria, but we
have limited knowledge regarding the clinical epidemiology of
these infections [1,3]. Most studies have focused on health care
related infections and associated risk factors. Moreover, these
studies have largely been based on information from medical
records. Thus, information on possible risk factors not regularly
noted in those records is sparse [4–20]. A large multinational
survey of infections caused by ESBL-producing Enterobacteriaceae
identified age $65 years, male sex and recent use of cephalospo-
rins as independent risk factors for CA-ESBL infections [3].
However, the authors expressed a poor predictive value of their
chosen model.
The present study was conducted in Norway. The yearly
Norwegian nationwide antimicrobial resistance surveillance pro-
gramme has shown a very low prevalence of infections caused by
ESBL-producing Enterobacteriaceae [21]. A prevalence of 1.6%
ESBL positive UTI in the Norwegian population was estimated for
2011. The prevalence is slowly increasing. A country with low
prevalence of infections with ESBL-producing bacteria is well
suited to identify risk factors for acquisition of ESBL, and a
nationwide prescription database makes Norway suitable for the
study of antibiotic use in detail [22]. Based on these advantages
and patient interviews we aimed to investigate whether patients
with ESBL positive CA-UTI have a different frequency of risk
factors of CA-UTI as compared to patients with ESBL negative
CA-UTI.
Materials and Methods
Design and Study Population
A case-control study was conducted at the Department of
Medical Microbiology, Vestre Viken Hospital Trust situated in a
mixed urban, suburban and rural area in the South-Eastern part
of Norway. Our two laboratories analyse samples from in- and
outpatients in an area comprising four hospitals and approxi-
mately 450.000 inhabitants (source population). The inclusion
period was from February 2009 to April 2011.
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The eligible population constituted all patients $18 years old
with a urine culture yielding E. coli or K. pneumoniae.10,000 CFU/
ml. The following exclusion criteria were used: i) patients who had
lived in Norway for ,1 year, ii) were unable to answer our
questionnaire, iii) had previously diagnosed infection caused by
ESBL-producing bacteria, and iv) patients with health care
associated UTI (i.e., hospitalized or residing in a nursing home
for .24 hours during the last 31 days).
The study population consisted of all patients willing to
participate with ESBL-positive UTI (case group) and randomly
selected patients with ESBL-negative UTI (control group)
(Figure 1).
The patients received written information and were invited to
participate by ordinary mail. Non-responders were contacted
twice. Acceptance was given by returning a signed consent form.
Ethics statement. The study was approved by the Regional
Committee for Medical and Health Research Ethics in South-
Eastern Norway (reference number: 2009/2037 BS-08901b).
Data Collection
Urine cultivation and bacterial identification were performed
using ChromID CPS3 agar and the VITEK-2 system (both
BioMerieux, Marcy l’Etoile, France). Antimicrobial susceptibility
testing and interpretations including ESBL screening were
performed using VITEK-2 or agar disc diffusion method
according to EUCAST recommendations and clinical breakpoints
[23].
Isolates resistant to cefpodoxime, cefotaxime or ceftazidime
were selected for confirmatory ESBL testing using the E-test
system (AB-Biodisk, BioMerieux). ESBL genotype analysis was
performed using PCR for blaCTX-M detection and group assign-
ment, as described [24]. Isolates negative for blaCTX-M were
analyzed using conventional blaTEM and blaSHV PCR and
sequencing, as described [25].
A structured interview was performed by a trained investigator
by telephone or in-person for community-based and hospitalized
patients, respectively. The questionnaire was sent to the partici-
pants in advance and included questions regarding the infection
for which they were included in the study, health condition
(Charlson Comorbidity Index [26]), contact with the health care
system in Norway and abroad (time and duration during the past 5
years), UTIs, antibiotic use, compliance with antibiotic prescrip-
tions, prostate disease, use of a urinary catheter during the past
year, oral and digestive health problems, international travel or
residency lasting $24 hours during the past five years (time since
returning home, duration and country), profession, personal
hygiene, household members, pets, eating habits (meals per week
of different foods and meals outside home), and recreational
swimming during the past year (location, number of times and
submergence of head).
In Norway antibiotics are available on prescription only. Date,
type and amount of antibiotic dispensed during the past five years
were obtained from The Norwegian Prescription Database [22].
Information about antibiotic use during hospitalization was
obtained from medical records.
Information on previous infections with ESBL-producing
bacteria was obtained from our laboratorỳs computer system.
Statistical Analysis
This case-control study was analysed using a pragmatic strategy,
which means that priority was not given to a specific hypothesis.
Univariate analyses were performed using Student’s t test,
Pearson’s chi-square test or Fisher’s exact test when appropriate.
The association between potential risk factors and infection caused
by ESBL-producing E. coli or K. pneumoniae was quantified by odds
ratio (OR) with 95% confidence interval (CI). Any variable with a
p,0.15 from the univariate analysis was considered a candidate
for the multivariate model. A manual backward stepwise
Figure 1. Selection of study population. aDementia (n = 1), unable to reach by phone (n = 2) and death (n = 2).
doi:10.1371/journal.pone.0069581.g001
Risk Factors for ESBL in Urinary Tract Infection
PLOS ONE | www.plosone.org 2 July 2013 | Volume 8 | Issue 7 | e69581
elimination procedure using a multivariate logistic regression
model was performed to identify independent risk factors.
Multivariate analyses were preceded by estimation of correlation
between risk factors. Evaluation of the predictive accuracy of the
models was assessed by calibration and discrimination. Calibration
was evaluated by the Hosmer and Lemeshow goodness-of-fit test.
A statistically non-significant Hosmer and Lemeshow result
(p.0.05) suggests that the model predicts accurately on average.
Discrimination was evaluated by analysis of the area under the
ROC curve. We defined acceptable discriminatory capability as
an area under the ROC curve greater than 0.7 [27]. Two-tailed p
values of ,0.05 were considered statistically significant. All
statistical analyses were conducted using PASW statistics software,
version 19.0 (IBM SPSS, Chicago, IL).
Results
Approximately 28,000 urine samples from 15,000 unique
patients were submitted to our department during the inclusion
period. A total of 359 (1.3%) samples yielded ESBL positive E. coli
(n = 342) or K. pneumoniae (n = 17). After exclusion 171 subjects with
ESBL UTI were invited to participate (case group). Also, 439
randomly selected control patients were invited to participate
(Figure 1).
Relevant background characteristics of the participants are
presented in Table 1. The cases and controls were in large similar.
Significantly younger age and the presence of diabetes mellitus
among cases were the two exceptions.
ESBL Genotyping
PCR and sequence analyses showed that 65%, 30%, and 5% of
the ESBL isolates belonged to the CTX-M group 1, CTX-M
group 9 and SHV group 5/12, respectively. TEM-type ESBLs
were not detected.
Antibiotic Use and Antibiotic Resistance
Data on antibiotic use are presented in Table 2. More than 90%
of the participants reported that they had completed all prescribed
courses of antibiotics received during the past 5 years. Antibiotic
use was more prevalent in the study population (59% during the
past three months before the infection) than in the age-adjusted
general Norwegian population (29% during the past year) – (data
from the Norwegian Prescription Registry [22]). This difference
was mainly due to increased use of antimicrobials used to treat
UTIs in the study population.
In general, ESBL-producing isolates expressed more co-
resistances compared to non-ESBL strains. For cases and controls
the proportion of non-susceptible strains were 59% and 13% for
ciprofloxacin, 78% and 24% for trimethoprim, 35% and 4% for
gentamicin, 4% and 2% for nitrofurantoin and 4% and 3% for
mecillinam, respectively.





(n = 190) Crude OR 95% CI p
Age in years, mean 6 SD 55619 64617 ,0.001
Female gender 88 (88%) 168 (88%) 0.96 0.45–2.0 0.92
Number of household members, mean 6 SD 2.461.3 2.161.1 0.09
Pets in household 30 (30%) 44 (23%) 1.4 0.82–2.5 0.20
Infection caused by Klebsiella pneumoniae 5 (5%) 13 (7%) 0.72 0.25–2.1 0.54
Hospitalization past yearc 21 (21%) 34 (18%) 1.2 0.66–2.2 0.52
Recurrent UTId 17 (17%) 47 (25%) 0.62 0.34–1.2 0.13
Charlson index score $3 11 (11%) 25 (13%) 0.83 0.39–1.8 0.64
Pulmonary disease 13 (13%) 25 (13%) 0.99 0.48–2.0 0.98
Rheumatic disease 9 (9%) 33 (17%) 0.47 0.21–1.0 0.05
Malignancy 6 (6%) 9 (5%) 1.3 0.45–3.7 0.64
Diabetes mellitus 12 (12%) 9 (5%) 2.7 1.1–6.8 0.02
Gastrointestinal disease 14 (14%) 29 (15%) 0.90 0.45–1.8 0.76
Cardiac disease 13 (13%) 31 (17%) 0.76 0.38–1.5 0.44
Renal dysfunction 7 (7%) 10 (5%) 1.35 0.50–3.7 0.56
Hepatic dysfunction 1 (1%) 1 (1%) 1.90 0.12–31 1.00
Cerebrovascular disease 2 (2%) 10 (5%) 0.36 0.08–1.7 0.23
Urinary catheter at any time during past year 15 (15%) 25 (14%) 1.1 0.56–2.2 0.74
aData are presented as the absolute number of patients with percentages in parentheses with the exception of age and household members, which is listed as mean
value 6 standard deviation (SD).
bSome variables have missing values (number of missing patients in parentheses): Household members (2), Charlson comorbidity index score (8) Pulmonary disease (2)
Rheumatic disease (1), Malignancy (2), Diseases of the gastrointestinal tract (1), Cardiac disease (4), Renal dysfunction (1), Hepatic dysfunction (1), Cerebrovascular
disease (2), Urinary catheter (6).
cExcluding the time period from 24 hours to 31 days before the urinary sample was taken. No patient had resided in a nursing home without being hospitalized in the
time period.
dTo quantify the number of UTIs for each patient in the preceding year, the number of prescriptions of three antimicrobial agents–trimethoprim, mecillinam, and
nitrofurantoin–were counted. In Norway, these agents are first choices for UTI treatment and are not used for other infections. Recurrent UTI was defined as $3 UTIs
during the past year.
doi:10.1371/journal.pone.0069581.t001
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Risk Factor Analysis
The results of the univariate analyses on risk factors are
presented in Table 3. Travelling to Asia, Middle East or Africa up
to 2 years in the past, recreational swimming, eating dinner at
restaurants and close occupational contact with humans were
identified as significant risk factors for ESBL UTI. Interestingly,
frequent consumption of fish meals (Figure 2), infrequent bath or
shower and digestive problems seemed to have a protective effect.
The results of the multivariate analyses are presented in Table 4.
Patients with an ESBL positive UTI had travelled 21 times more
to Asia, Middle East or Africa during the past 6 weeks than
patients with a non-ESBL UTI, and this was the strongest
predictor for ESBL UTI. Travel to the same areas in the period
from 6 weeks to 24 months in the past was to a lesser degree
associated with ESBL UTI (OR 2.3, 95% CI: 1.2–4.4, p = 0.017).
The variables regarding (time since) travel abroad were also
analysed as continuous variables but this did not influence the
results. Recreational freshwater swimming was identified as an
independent risk factor, and patients with ESBL UTI had swum
twice as frequent in freshwater as patients with ESBL negative
UTI.
Previously known risk factors such as recent antibiotic use and
diabetes mellitus were also identified as independent risk factors.
Age and weekly fish meals were found to be putative protective
factors.
The final multivariate model was applied to participants with
infection caused by E. coli only and this did not change any trends
in the results (data not shown).
The Hosmer and Lemeshow goodness-of-fit test was not
significant indicating a satisfactory fit of the model (x2 = 5.64,
df = 8, p=0.69). The area under the ROC curve was 0.83 (95%
CI: 0.79–0.88) indicating a good discriminative ability between
ESBL-positive and ESBL-negative patients.
Discussion
This is to our knowledge the first population-based study to
identify risk factors for acquisition of CA-ESBL infections in a low
prevalence country. International travel was identified as the most
important risk factor for ESBL positive CA-UTI in this study.
Most travel-associated ESBL UTIs occurred during the first six
weeks after returning home. This observation is consistent with
previous studies and adds new information about the time course
between colonization during travel and actual infection [5,28,29].
The area associated with the highest risk (Asia, Middle East and
Africa) corresponds well with areas previously associated with a
high rate of colonization in returning travellers [28].
This observation contrasts a recent French study. Nicolas-
Chanoine and co-workers did not identify travelling abroad for
Table 2. Comparison of the antibiotic usage during the last 90 days prior to inclusion in the study population with and without





(n = 190) Crude OR 95% CI p
No antibiotic past 90 daysb 38 (38%) 80 (42%) 0.84 0.51–1.4 0.50
Mecillinam 15 (15%) 45 (24%) 0.57 0.30–1.1 0.08
Macrolides 7 (7%) 5 (3%) 2.8 0.86–9.0 0.12
Tetracyclines 5 (5%) 6 (3%) 1.6 0.48–5.4 0.52
Fluoroquinolones 14 (14%) 3 (2%) 10 2.84–36 ,0.001
Nitrofurantoin 8 (8%) 16 (8%) 0.95 0.39–2.3 0.90
Trimethoprim or trimethoprim/sulfamethoxazole 16 (16%) 42 (22%) 0.67 0.36–1.3 0.22
b-lactams except mecillinamc 18 (18%) 18 (9%) 2.1 1.0–4.2 0.04
- Phenoxymethylpenicillin 11 (11%) 12 (6%) 1.8 0.78–4.3 0.16
- Amoxicillin 3 (3%) 6 (3%) 0.95 0.23–3.9 1.0
- Cloxacillin 3 (3%) 1 (1%) 5.8 0.60–57 0.12
- Cephalexin 4 (4%) 2 (1%) 3.9 0.70–22 0.19
Methenamine hippurate 2 (2%) 15 (8%) 0.24 0.05–1.1 0.04
aNumber of subjects who had used at least one dose in the past 90 days.
bSix cases and 17 controls received an antimicrobial agent at the day before the urinary sample only.
cPenicillin, amoxicillin, cloxacillin or cephalexin (some patients used more than one type).
doi:10.1371/journal.pone.0069581.t002
Figure 2. Decreasing riska of ESBL-positive urinary tract
infection with increasing number of fishmeals per weekb.
aControlling for the variables: Travelling to Asia, Middle east or Africa,
Use of fluoroquinolones the past 90 days, Use of b-lactams except
mecillinam the past 90 days, Diabetes mellitus,Recreational freshwater
swim past year and age. bReference category: eating #1 fishmeal per
week.
doi:10.1371/journal.pone.0069581.g002
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(n = 190) Crude OR 95% CI p
Travel destinations abroad within the past 6 weeksc
- America or Oceania (including Japan) 0 (0%) 1 (1%) 0.65 1.00
- Asia, Middle East or Africa 23 (23%) 2 (1%) 28 6.5–122 ,0.001
- Europe 11 (11%) 13 (7%) 1.7 0.72–3.9 0.22
Travel destinations abroad between the previous 6 weeks to 24 monthsc
- America or Oceania (including Japan) 13 (13%) 17 (8.9%) 1.5 0.71–3.3 0.28
- Asia, Middle East or Africa 39 (39%) 36 (19%) 2.7 1.6–4.7 ,0.001
- Europe 67 (67%) 108 (57%) 1.5 0.93–2.6 0.09
Travel destinations abroad between the previous 24 months to 5 yearsc
- America or Oceania (including Japan) 10 (10%) 15 (7.9%) 1.3 0.56–3.0 0.54
- Asia, Middle East or Africa 26 (26%) 38 (20%) 1.4 0.79–2.5 0.24
- Europe 55 (55%) 92 (48%) 1.3 0.8–2.1 0.29
Recreational swimming past year
- In seawater 68 (68%) 98 (52%) 2.0 1.2–3.3 0.01
- In freshwater 26 (26%) 30 (16%) 1.9 1.0–3.4 0.04
- In swimming pool 53 (53%) 78 (41%) 1.6 0.99–2.6 0.05
- Usually submerges head during recreational swimming 41 (41%) 56 (30%) 1.6 0.97–2.7 0.06
Eating habits
- Number of fish meals per week, mean 6SD 2.161.1 2.761.4 0.67 0.54–0.83 ,0.001
- Number of meat meals per week, mean 6SD 3.561.4 3.361.3 1.1 0.94–1.3 0.22
- Organic food $1/week 24 (24%) 40 (22%) 1.2 0.66–2.1 0.58
- Dinner at a restaurant $2/month 29 (29%) 28 (15%) 2.4 1.3–4.3 0.003
- Prefers meat well done 33 (34%) 74 (40%) 0.77 0.46–1.3 0.33
Close occupational contact with humansd 29 (29%) 31 (17%) 2.1 1.2–3.7 0.01
Bath or shower #2 times/week 12 (12%) 44 (23%) 0.46 0.23–0.92 0.03
Oral/dental health problems 13 (13%) 28 (15%) 0.85 0.42–1.7 0.65
Digestive problems (constipation or diarrhoea) 25 (26%) 75 (40%) 0.51 0.30–0.87 0.01
aData are presented as the absolute number of patients with percentages in parentheses with the exception of fish and meat meals, which is listed as mean value6 SD.
bSome variables have missing values (number of missing patients in parentheses). Usually submerges head during recreational swimming (7), Organic food (7), Dinner in
restaurant (2), Prefers meat well done (8), Close occupational contact with humans (6), Bath or shower (3), Digestive problems (6).
cOnly trips lasting .24 hours outside the Nordic countries (Norway, Denmark, Finland, Sweden and Iceland) are included.
dSelf-reported close occupational contact with humans.
doi:10.1371/journal.pone.0069581.t003
Table 4. Independent risk factors of ESBL positive community acquired urinary tract infection identified using multivariate logistic
regression analysis.
Variable Level Adjusted OR 95% CI P
Travelling to Asia, Middle East or Africaa
- During the past 6 weeks yes/no 21 4.5–97 ,0.001
- Between the previous 6 weeks to 24 months yes/no 2.3 1.2–4.4 0.017
Use of fluoroquinolones the past 90 days yes/no 16 3.2–80 ,0.001
Use of b-lactams except mecillinam in the past 90 days yes/no 5.0 2.1–12 ,0.001
Diabetes mellitus yes/no 3.2 1.0–11 0.051
Recreational freshwater swim past year yes/no 2.1 1.0–4.3 0.040
Age 5 year increase 0.89 0.82–0.97 0.014
Number of fish meals per week 1 meal increase 0.68 0.51–0.90 0.008
aOnly trips lasting .24 hours are included.
doi:10.1371/journal.pone.0069581.t004
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.14 days during the past 6 months as a risk factor for an ESBL-
positive (blaCTX-M-15) infection in hospitalized patients [6]. In our
study, travelling abroad for .14 days was a strong predictor of
ESBL UTI when using blaCTX-M-1 -positive infections as an end-
point (data not shown). It is likely that the importance of travel as a
risk factor will differ between the French hospitalized population
and the Norwegian non-hospitalized population in our study. Also,
the proportion of ESBL-producing clinical isolates of Enterobacte-
riaceae in France is higher than in Norway [30]. Therefore, travel
abroad from France will not have the same relative impact on the
colonization and infection rate as travelling abroad from Norway.
This emphasizes the importance of investigating these risk factors
in a low prevalence area.
Recent antibiotic use is a known risk factor for infections caused
by ESBL-positive bacteria [3,7,8,11,31]. We found that recent use
of fluoroquinolones was strongly associated with an ESBL-positive
UTI, supporting the results from several other studies [7,8,31].
Interestingly, the use of mecillinam as opposed to other b-
lactams, was not associated with ESBL-positive CA-UTI. This
may be because the oral formulation of mecillinam, pivmecillinam,
is a pro-drug with minor effects on the intestinal flora [32].
Moreover, mecillinam has a selective activity against Gram-
negative bacteria and is more stable against ESBL hydrolysis
compared to most penicillins [33].
Recreational swimming in freshwater was identified as an
independent risk factor for ESBL UTI. ESBL-producing bacteria
like E. coli have been detected in environmental water [34–36].
Furthermore, outbreaks of E. coli O157:H7 have been linked to
swimming in contaminated freshwater [37]. Swimming may
therefore be a risk factor for intestinal colonization with E. coli
with ESBL and any subsequent UTI may be caused by a such
newly acquired ESBL-producing strain from the water [38]. This
finding highlights a possible link between environmental pollution
and antimicrobial resistance, but will have to be substantiated
before any conclusions can be drawn [39].
Interestingly, eating fish was associated with a reduced risk of
ESBL UTI (Figure 2). Each weekly fish meal reduced the risk of an
ESBL positive infection with about 30%. It is clear that eating
habits influence the microbial flora in the gut [40]. However,
whether eating fish may affect the resistance pattern of the gut
microbial flora and potentially lower the risk of ESBL UTI
remains speculative and eating fish may be a marker of a more
fundamental risk factor not measured.
Retail chicken meat has recently been implicated as a possible
source of ESBL-colonization [41]. We did not specifically
investigate this possible risk factor, but ESBL-producing bacteria
have only very rarely been found in the Norwegian food chain
[42].
In our study, patients infected with an ESBL-producing E. coli
or K. pneumoniae were significantly younger than the control
patients. In two studies with similar design but including
hospitalized patients, no association between age and ESBL
positive infection was found [8,43]. This suggests that the
epidemiology of ESBL infections differs in Norway or among
non-hospitalized patients.
Limitations
Limitations include the possibility of selection bias due to non-
participation and a potential problem with differential misclassi-
fication of exposure because the interviewers were not masked to
the status of the patient being a case or a control. To minimize the
latter the questionnaires were sent to the participants in advance
and interview training was given.
We did not use the Friedman criteria for health care acquired
infections and thus patients with health care system contact during
the past 2–3 months and patients catheterized the past month
were included for analysis [44]. Excluding these patients (n = 30)
did, however, not change any trends in the results (data not
shown).
Finally, our study may overestimate the use of antibiotics as a
risk factor since patients in the control group, with susceptible
bacteria, may be less likely to have used antibiotics. This is because
non-ESBL E. coli and K. pneumoniae are more susceptible to
antibiotics than ESBL-producers, and recently treated patients
with such susceptible strains are therefore less likely to show up in
the control group [45].
In summary, we have addressed the knowledge gap concerning
risk factors for CA-UTIs caused by ESBL-producing bacteria [3].
Previously suspected risk factors for ESBL UTI have been
supported and possible new ones uncovered. Our study shows
that the predictive antimicrobial resistance pattern in uropatho-
genic E. coli is heavily influenced by the country the patient has
recently visited [28,46]. Thus, information on recent travel is
important when treating patients with serious infections that may
involve this organism. Physicians in low-prevalence countries
should consider ESBL when treating UTI in patients who have
visited countries in Africa, The Middle East or Asia during the past
six weeks [28,46].
An association between recreational swimming and ESBL UTI
was detected. Further investigation to examine the possible
negative impact of environmental pollution with ESBL-producing
Enterobacteriaceae seems warranted.
Finally, eating fish regularly was associated with a protective
effect against ESBL UTI. If this is confirmed in other studies, an
interesting link between diet and infection has been established.
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